DNP875 Module 6 Screening Benefit and Harm Discussion Example

Reviewed by Maren Hollowell, MSN, RN Aspen University Updated October 2026

This DNP875 Module 6 sample post weighs the benefits and harms of blood pressure screening booths at a county fair for adults aged 18 to 39 with no known risk factors. In Aspen University's Population Health and Person-Centered Care, Module 6 is a discussion on screening, so DNP students must set benefit against harm. The post reports the 2021 task force statement's intervals: yearly from age 40 or with risk, every three to five years for lower-risk young adults with a prior normal reading. Guirguis-Blake's evidence review supplies the harm: office screening had a pooled sensitivity of 0.54, and office confirmation a specificity of only 0.55 against ambulatory monitoring. A noisy fair booth will do worse. The post plans two rested readings by Muntner's measurement standards, confirmation outside the clinic and consent before recording names.

CourseDNP875 Population Health and Person-Centered Care
ModuleModule 6
Paper typeDiscussion post
LengthAbout 425 words
FormatDiscussion post with APA 7 citations
SchoolAspen University
ProgramDNP
UpdatedOctober 2026

Free sample paper for DNP875 Module 6

1

Module 6 Discussion: Initial Post

One Reading at the County Fair: Weighing the Benefits and Harms of Blood Pressure Screening for Adults Aged 18 to 39

Our county health collaborative is planning blood pressure screening booths at the county fair, where many attendees are young adults who rarely see a clinician. The group I want to consider is adults aged 18 to 39 without known risk factors. Screening them has real benefits, but also harms that are easy to overlook when the goal is to find as many cases as possible.

The benefit case is solid. The national task force's guidance covers every adult from age 18 onward, annually for those 40 and older or at increased risk, and every three to five years for adults aged 18 to 39 who are not at increased risk and had a prior normal reading (US Preventive Services Task Force et al., 2021). Many young adults with hypertension are unaware of it, and earlier detection allows lifestyle change and treatment years before damage accumulates.

The harms come from the limits of a single reading. The evidence review supporting the recommendation found that initial office-based screening had a pooled sensitivity of 0.54 and specificity of 0.90, and that office-based confirmation, when compared with ambulatory monitoring, had a specificity of only 0.55, meaning many people with elevated office readings do not have sustained hypertension (Guirguis-Blake et al., 2021). A fair booth, with noise, recent exertion, and nerves, is likely to perform worse than a clinic. For a healthy 25-year-old, the main harm of screening is not the cuff; it is a diagnosis that follows from one bad reading. A mislabeled young adult may start medication unnecessarily, face higher life insurance premiums, or worry needlessly.

That is why the task force wants high readings confirmed away from the clinic, with home or ambulatory monitoring, before anyone is diagnosed or treated (US Preventive Services Task Force et al., 2021). Our booth plan should therefore treat an elevated reading as a reason for follow-up, not a diagnosis: take two readings after five minutes of seated rest, using the positioning and cuff-size standards in the national guidance on blood pressure measurement (Muntner et al., 2019), give anyone above threshold a written explanation, and connect them to a clinic that offers home monitoring or ambulatory confirmation. People with very high readings or symptoms would be referred the same day. We should also avoid collecting names and results at the booth unless the person consents to follow-up.

Has anyone run community screening events? How did you handle follow-up for elevated readings?

What this page is doingThe post names a specific group and setting, presents the benefit with the current recommendation, quantifies the harm from test accuracy evidence reported accurately, and turns the balance into a concrete screening protocol, ending with a question. The highlighted sentence captures the main harm for this group.
2

References

Guirguis-Blake, J. M., Evans, C. V., Webber, E. M., Coppola, E. L., Perdue, L. A., & Weyrich, M. S. (2021). Screening for hypertension in adults: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA, 325(16), 1657-1669. https://doi.org/10.1001/jama.2020.21669

Muntner, P., Shimbo, D., Carey, R. M., Charleston, J. B., Gaillard, T., Misra, S., Myers, M. G., Ogedegbe, G., Schwartz, J. E., Townsend, R. R., Urbina, E. M., Viera, A. J., White, W. B., & Wright, J. T. (2019). Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Hypertension, 73(5), e35-e66. https://doi.org/10.1161/HYP.0000000000000087

US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Stevermer, J., Tseng, C.-W., & Wong, J. B. (2021). Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA, 325(16), 1650-1656. https://doi.org/10.1001/jama.2021.4987

DNP875 Module 6 instructions, in plain terms

Aspen's DNP875 Module 6 discussion commonly asks whether a screening program does more good than harm for one defined group. Name the group and setting precisely. State the current recommendation with its intervals and source. Describe the benefits with evidence. Describe harms concretely, using test accuracy figures such as sensitivity and specificity, and explain what false positives mean for a person. Adjust for your setting. Propose a design that keeps the benefit and reduces the harm. Close by putting a question to the group. Stay under the length cap, and in replies bring a different setting or test, since replies are graded on what they add to the discussion.

How the DNP875 Module 6 example is put together

The post opens with the fair booth and the group of interest, young adults who rarely see a clinician. The benefit paragraph states the task force's screening intervals and the value of early detection. The harm paragraph reports the review's sensitivity and specificity figures and explains why a booth may perform worse than a clinic. A highlighted sentence names the main harm for a healthy 25-year-old: a diagnosis from one bad reading. Consequences follow, from unnecessary medication to insurance premiums and worry. The design paragraph sets two readings after rest, correct cuff size, a written explanation, referral for confirmation by home or ambulatory monitoring and same-day referral for very high readings. A note on privacy and a question for classmates close it.

DNP875 Module 6 rubric: what earns full marks

Discussion posts in DNP875 earn marks for a defined group, accurate recommendations, evidence on benefits and harms, a design that responds to both and an invitation to peers. Marks come here by using test accuracy figures to make harm concrete rather than stating that screening can cause false positives. The US Preventive Services Task Force's 2021 statement, Guirguis-Blake and colleagues' 2021 evidence review and Muntner and colleagues' 2019 measurement statement are each used for a distinct purpose. Adjusting for a noisy fair setting shows judgment. The booth design keeps the benefit while preventing diagnosis from a single reading, which graders read as applied population health reasoning rather than a general opinion about screening.

Common DNP875 Module 6 mistakes, and how to avoid them

Screening posts often argue that more screening is always better. Weigh harms too. Another common gap is citing the recommendation without its intervals or age groups. State them. Students also mention false positives without numbers. Use sensitivity and specificity from a review. Adjust for your setting, since a booth differs from a clinic. Propose a design that requires confirmation before diagnosis. Address privacy. Keep within the word count. In replies, add another setting or a different screening test. Finally, explain what happens to a person after an elevated reading, because follow-up is where community screening most often fails, and where the post can offer the most practical value to classmates.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

More DNP875 and DNP sample papers

DNP875 Module 6 questions, answered

What does DNP875 Module 6 usually ask for?

The module's discussion often asks you to weigh the benefits and harms of screening for a specific group, using current recommendations and evidence. Aspen does not publish module deliverables, so your classroom's instructions govern.

How often should young adults be screened for hypertension?

The USPSTF recommends screening adults aged 18 to 39 who are not at increased risk and had a prior normal reading every three to five years, and annually for adults 40 and older or at increased risk.

Why confirm high blood pressure outside the clinic?

Single office readings can be falsely high. The evidence review found office-based confirmation had low specificity compared with ambulatory monitoring, so the task force recommends out-of-office measurement before diagnosis and treatment.

Where can I find a free DNP875 Module 6 sample paper?

The full DNP875 Module 6 post is above, weighing benefits and harms of fair-booth blood pressure screening for adults aged 18 to 39.

What is the main harm of screening young adults in DNP875 Module 6?

A diagnosis based on one high reading. Office confirmation had a specificity of only 0.55 against ambulatory monitoring, so the post requires confirmation outside the clinic before any diagnosis.